Dr Laith M Abbas Al-Huseini

Slides:



Advertisements
Similar presentations
Chapter 51 Diuretic Agents
Advertisements

Diuretics Clinical Conditions Requiring Diuretic Therapy:
THIAZIDE DIURETICS Secreted into the tubular lumen by the organic acid transport mechanisms in the proximal tubule Act on the distal tubule to inhibit.
Diuretics. A. Kidney functions Kidneys have a number of essential functions:
Chapter 41 Diuretics 1.
 2009 Cengage-Wadsworth Chapter 14 Body Fluid & Electrolyte Balance.
Diuretics and Dehydrants. §1 Diuretics Abnormalities in fluid volume and electrolyte composition are common and important clinical problems. Drugs that.
DIURETICS. Functions of the kidneys Volume Acid-base balance Osmotic pressure Electrolyte concentration Excretion of metabolites and toxic substances.
Urinary System Spring 2010.
Diuretics A diuretic is a substance that increases the rate of urine volume output Most diuretics also increase urinary excretion of solutes, especially.
Diuretics. Why do we want to know about diuretics? What do kidneys do? What can go wrong? Interventions that can be used how do they work? Effects, side.
Excretion of Water and Electrolytes
BIMM118 Renal Pharmacology Diuretics: Carbonic Anhydrase Inhibitors Thiazides Loop Diuretics Potassium-sparing Diuretics.
Renal Structure and Function. Introduction Main function of kidney is excretion of waste products (urea, uric acid, creatinine, etc). Other excretory.
DIURETICS Brogan Spencer and Laura Smitherman. What is a diuretic? Substance that promotes the formation (excretion) of urine.
Control of Renal Function. Learning Objectives Know the effects of aldosterone, angiotensin II and antidiuretic hormone on kidney function. Understand.
Diuretics Chris Hague, PhD
DIURETICS By: Prof. A. Alhaider.
Diuretics. From Knauf & Mutschler Klin. Wochenschr : % 20% 5% 4.5% 0.5% Volume 1.5 L/day Urine Na 100 mEq/L Na Excretion 155 mEq/day.
Diuretic Agents in Hypertension and other disorders
 Paired kidneys  A ureter for each kidney  Urinary bladder  Urethra 2.
Prof. Hanan Hagar Pharmacology Department
DIURETIC DRUGS.
1-Overview 2-Classification 3-Indiviual drugs 1-Indications of Diuretics. 2-Adverse effects. 3-Mannitol and Carbonic Anhydrase inhibitors.
BYL Nair Ch. Hospital, Mumbai
Lecture – 3 Dr. Zahoor 1. TUBULAR REABSORPTION  All plasma constituents are filtered in the glomeruli except plasma protein.  After filtration, essential.
Diuretics the role of different portions of the nephron in ion exchange; the sites of action and pharmacology of diuretics; the therapeutic applications.
Diuretics Diuretics Heny Ekowati Pharmacy Departement Faculty of Medicine and Health Sciences.
CARBONIC ANHYDRASE INHIBITORS ACETAZOLAMIDE E It is a sulfonamide derivative. It is a sulfonamide derivative. noncompetitively but reversible inhibits.
Diuretics From Diuresis to Clinical Use
DIURETICS Part 1 Prof. Hanan Hagar Pharmacology Unit.
CHAPTER © 2012 The McGraw-Hill Companies, Inc. All rights reserved. 25 Diuretics.
DIURETIC DRUGS (DR.Farooq Alam) DIURETIC DRUGS (DR.Farooq Alam)
DIURETICS Part 1 Prof. Hanan Hagar Pharmacology Department.
Prof. Hanan Hagar Pharmacology Department
Tambahkanlah Ilmuku dan Berilah aku pengertian dengan baik Tiada sia-sia Meraih Ilmu dan Mengamalkannya.
DIURETICS Diuretics are drugs which increase the excretion of sodium and water from the body by an action on the kidney. Their primary effect is to decrease.
DR. MOHD NAZAM ANSARI.  Some of pathological conditions associated with retention of sodium and water in the body e.g. Congestive Heart failure, Pulmonary.
Urinary system Designed by Pyeongsug Kim ©2010 Picture from
Vilasinee Hirunpanich B.Pharm(Hon), M.Sc In Pharm (Pharmacology)
Diuretic Agents.
Diuretics and Antihypertensives
Pharmacology – I [PHL 313] DiureticsDiuretics Dr. Hassan Madkhali Assistant Professor Department of Pharmacology E mail:
Mosby items and derived items © 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 21 Diuretic Agents.
DIURETICS By: Prof. A. Alhaider 1433 H. Anatomy and Physiology of Renal system ► Remember the nephron is the most important part of the kidney which regulates.
DIURETICS By: Prof. A. Alhaider. Anatomy and Physiology of Renal system ► Remember the nephron is the most important part of the kidney that regulates.
What is high ceiling diuretic & Why?
Diuretics Clinical Conditions Requiring Diuretic Therapy: Cerebral Edema Cerebral Edema Pulmonary Edema Pulmonary Edema Hypertension Hypertension Congestive.
Diuretic Agents. Carbonic Anhydrase Inhibitors.
Tubular Reabsorption and regulation of tubular reabsorption Tortora Ebaa M Alzayadneh, PhD.
Diuretics Blake Briggs, Class of 2017.
Objectives for Lecture on Diuretics
Kidney Functions and regulation
Renal mechanisms for control ECF
Sodium Channel Inhibitors
(Furosemide, Ethacrynic acid, Bumetanide and Torsemide) DIURETICS: LOOP DIURETICS (Furosemide, Ethacrynic acid, Bumetanide and Torsemide)
Renal tubule transport mechanisms
Loop diuretics Domina Petric, MD.
D. C. Mikulecky Faculty Mentoring Program Virginia Commonwealth Univ.
Potassium-sparing diuretics
Domina Petric, MD Aquaretics.
Thiazides Domina Petric, MD.
Sodium Homeostasis Sodium is an electrolyte of major importance in the human body. It is necessary for : normal extracellular volume dynamics  Na in ECF.
Kidney Functions and regulation
Diuretics By S.Bohlooli, PhD.
Kidney Functions and regulation
Diuretic Drugs.
Diuretic Agents.
REGULATION OF K,Ca, PHOSPHATE & MAGNISIUM
Ass. Prof. Dr. Naza M. Ali Lec G2 19 May 2019 G1 22 May 2019
Presentation transcript:

Dr Laith M Abbas Al-Huseini Diuretics (I) Dr Laith M Abbas Al-Huseini M.B.Ch.B., M.Sc., M.Res., Ph.D.

Diuretics Drugs increase the volume of urine excreted. Inhibitors of renal ion transporters that decrease the re-absorption of Na+ at different sites in the nephron. As a result, Na+ and other ions, such as Cl−, enter the urine in greater than normal amounts along with water, which is carried passively to maintain osmotic equilibrium. They increase the volume of urine and often change its pH, as well as the ionic composition of the urine and blood. In addition to the ion transport inhibitors, other types of diuretics include osmotic diuretics, aldosterone antagonists, and carbonic anhydrase inhibitors. Most commonly used for management of abnormal fluid retention (edema) or treatment of hypertension.

(DESCENDING LOOP OF HENLE) (ASCENDING LOOP OF HENLE) The filtrate entering here is isotonic due to water reabsorption in this area. Tubular fluid becomes concentrated (Hypertonic) (Three fold increase in salt concentration). (ASCENDING LOOP OF HENLE) ASCENDING LOOP OF HENLE (Medullary part lined by cuboidal cells). Unique. Impermeable to water.

Active reabsorption of Na+, K+ & Cl- is mediated by a Na+/K+/2Cl- Co-transporter. Mg++ and Ca++ enter the interstitial fluid. 25% to 30% of tubular NaCl returns to the interstitial fluid (blood). So, Loop of Henle is called diluting region. A major site for salt reabsorption. 2. ASCENDING LOOP OF HENLE: Thick Ascending Loop (TAL) (Cortical part lined by flattened cells). Impermeable to water. Salt reabsorption continues but through Na+-Cl- symporters. Tubular fluid gets further diluted.

DISTAL CONVULATED TUBULE Impermeable to water. 10% of filtered NaCl is reabsorbed via Na+/Cl- transporter that is sensitive to Thiazide diuretics. Calcium reabsorption mediated by Na+/Ca++ exchanger into the interstitial fluid. Ca++ excretion is regulated by parathyroid hormone in this portion of the tubule.

COLLECTING TUBULE & DUCT Na+, K+, water reabsorption. Na+ enters through channels to tubular cells but absorption in blood relies on Na+/K+-ATPase. Aldosterone receptors in tubular cells influence Na+ reabsorption & K+ secretion. Absorption of Na+ at this site occurs through a specific amiloride sensitive Na+ channel & controlled by aldosterone. ADH promotes reabsorption of water from the collecting tubule mediated by cAMP.

GFR is dependant on pumping action of heart, magnitude of renal blood flow and relative dimensions of afferent & efferent glomerular vessels. RAS with distal tubular reabsorption:- → Angiotensin II produced in kidney has direct effect on intrarenal vascular beds as well as salt & water reabsorption. → Sympathetic stimulation→ ↑es renin release→ Tubular transport. →Directly enhance reabsorption of salt & water. PGs→ modulates renal circulation & renin release. PGE2→inhibits ADH & has direct effect on tubular re-absorption.

Classification of Diuretics Very Potent Diuretics (Loop Diuretics):- Furosemide, Ethacrynic acid,Torsemide, Bumetamide, Peretanide, Indacrinone. B. Moderately Potent Diuretics:- Thiazide Diuretics : Bendrofluazide, Clopamide, Hydrochlorthiazide, Chlorthalidone, Chloroxolone, Indapamide, Polythiazide, Cyclopenthiazide. C. Potassium Sparing Diuretics:- Triamterene, Spironolactone, Amiloride.

Classification of Diuretics D. Weak Diuretics:- Osmotic Diuretics: Electrolytes: Sodium Chloride, Potassium citrate, Potassium carbonate, Potassium acetate, Potassium chloride. Nonelectrolytes: Mannitol, Isosorbide, Sucrose, Urea, Glycerol. Acidifying salts: Ammonium chloride, Arginine hydrochloride. Xanthine derivatives: Aminophylline, Theophylline Carbonic anhydrase inhibitors: Acetazolamide, Dichlorphenamide, Ethozolamide, Methazolamide

Loop Diuretics (High ceiling diuretics) Inhibitors of Na+ K+ 2Cl- Co-transporter. Inhibit Na+ & Cl- re-absorption. Produce venodilator action, directly or indirectly by releasing renal factor. Increased H+ & K+ loss. Thus may produce metabolic alkalosis. Increase in Ca++ & Mg++ concentration & decreased excretion of uric acid. They also potentiate the action of Thiazides. The excretion of Na+ continues even if ECF is less & hence may result into dehydration & hypotension.

Therapeutic Uses: Diuretic actions of Loop Diuretics: Oedema due to cardiac failure, hepatic disease, nephrotic syndrome. Acute pulmonary edema & cerebral edema. Acute chronic renal failure. Barbiturate poisoning & salicylate poisoning. Nondiuretic action of Loop Diuretics: As an antihypertensive. Idiopathic calcium urolithiasis. In Hypocalcaemia. Diabetes insipidus. Hyponatremic states due to water retention. Glaucoma

Adverse effects: Hypokalemia, so used with potassium sparing diuretics. Hyponatremia, dehydration & metabolic acidosis. Hyperglycemia & hyperuricemia. Weakness, fatigue, dizziness, cramps & myalgia. Prostatic hypertrophy, ototoxicity, cardiac arrest after IV injection. Hepatic insufficiency & gastric upset. Orthostatic hypotension.

1) Furosemide Potent, oral, diuretic, possessing halogenated salfamoyl benzene ring common to Thiazide diuretics. Thick ascending loop of Henle. Blocks Na+-K+-2Cl- symport. IV administration increases the renal blood flow. It increases PGE2 synthesis in the kidneys, which has a locally protective, vasodilator effect. In physiological or pharmacological stress, it counters the intrarenal vasoconstriction. Furosemide attaches to the Cl- binding site of protein (Na+ K+ 2Cl-) to inhibit its transport function.

Pharmacological actions:- Kidneys:- Excretion of Na+, K+, Cl-, PO4-. Excessive chloride loss →hypochloremic alkalosis. K+ loss→ Hypokalemia.( Less marked with Furosemide than Thiazides). Little change in Urine pH. Potent renin releasers. Blood vessels & BP:- IV furosemide dilates peripheral vasculature, Lowers the arterial BP, rapid venous pooling of blood, reducing cardiac preload & afterload. Metabolic actions:- ↑sed blood uric acid & disturbances of glucose tolerance, ↑sed blood urea. Ca++ & Mg++ excretion also ↑ses.

Pharmacokinetics:- Absorbed orally, Bioavailability 60-100%. Lipid solubility is low, Food reduces bioavailability. Onset of action is quick & short. Excreted within 4 hours. 50% excreted unchanged, rest conjugated with glucuronide in kidney.

2) Torsemide Three times more potent than furosemide. Oral absorption more rapid and complete. 80% metabolized in liver. t 1/2= 3.5 hrs. Duration of action= 4-8 hrs. Used in hypertension & edema.

3) Bumetanide 40 times more potent than furosemide. Onset & duration and its effect on electrolyte excretion are similar to furosemide. 80% absorption. It is metabolized in liver & its half life is not prolonged in renal insufficiency. Axosemide, Tripamide, Piretanide are other diuretics belonging to the furosemide group.

Ethacrynic acid An unsaturated ketone derivatives of Phenoxyacetic acid, is a potent oral diuretic like furosemide. Chemically unrelated to diuretic drugs but same effects as of furosemide. Max. diuresis within 2-3 hrs after giving orally. It can be used in edematous states, especially in patients allergic to sulphonamides. Less used because prone to cause adverse effects which are similar to those of furosemide.

Interactions Potentiate all other antihypertensives. This interaction is intentionally employed in therapeutics. Hypokalaemia induced by these diuretics: Enhances digitalis toxicity. Produces polymorphic ventricular tachycardia with quinidine and other antiarrhythmics. Potentiates competitive neuromuscular blockers and reduces sulfonylurea action. Loop diuretics + aminoglycoside antibiotics – both ototoxic and nephrotoxic → additive toxicity. Cotrimoxazole + loop diuretics- thrombocytopenia.

Indomethacin/ NSAIDs + Loop diuretics- diminishes diuretic and antihypertensive effect of loop diuretics. Probenecid + furosemide and thiazides-competitively inhibits tubular secretion of furosemide and thiazides,decreases their action by reducing the concentration in the tubular fluid, while diuretics diminish uricosuric action of probenecid. Serum lithium level rises when diuretic therapy is instituted. This is due to enhanced reabsorption of Li+ (and Na+) in PT. Furosemide and warfarin/ Clofibrates: Displacement of plasma protein binding of warfarin

Resistance to Loop Diuretics Renal insufficiency . Decreased access of diuretics to its site of action due to low GFR and low proximal tubular secretion. Nephrotic syndrome. Binding of diuretic to urinary protein, other pharmacodynamic causes. Cirrhosis of liver. Abnormal pharmacodynamic hyperaldosteronism CHF. lmpaired oral absorption due to intestinal congestion, decreased renal blood flow and glomerular filtration, lncreased salt reabsorption in PT.